Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,258 | 3,923 | 3,495 | 4,473 | 5,781 |
| Marketable Securities | 1,089 | 1,662 | 1 | 178 | 135 |
| Receivables | 438 | 322 | 211 | 181 | 210 |
| TOTAL | $11,021 | $5,948 | $3,822 | $5,023 | $6,415 |
| Non-Current Assets | |||||
| Intangibles | 95 | 97 | 100 | 103 | 106 |
| Other Non-Current Assets | 28 | 38 | 47 | 55 | 64 |
| TOTAL | $123 | $135 | $148 | $158 | $170 |
| Total Assets | $11,143 | $6,083 | $3,970 | $5,181 | $6,585 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,760 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,140 | 742 | 697 | 525 | 702 |
| Other current liabilities | 1,757 | 2,369 | 2,179 | 2,318 | 2,983 |
| TOTAL | $2,905 | $4,891 | $2,904 | $2,879 | $3,724 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $7 |
| Total Liabilities | $2,905 | $4,891 | $2,904 | $2,879 | $3,731 |
| Shareholders' Equity | |||||
| Common Shares | 35,949 | 26,403 | 25,570 | 25,338 | 24,759 |
| Retained earnings | -31,734 | -27,880 | -27,192 | -25,878 | -25,094 |
| Other shareholders' equity | 4,024 | 2,670 | 2,688 | 2,841 | 3,189 |
| TOTAL | $8,238 | $1,193 | $1,066 | $2,302 | $2,854 |
| Total Liabilities And Equity | $11,143 | $6,083 | $3,970 | $5,181 | $6,585 |